Results 41 to 50 of about 38,433 (267)

Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies [PDF]

open access: yes, 2009
Some autoimmune conditions are associated with increased risk of lymphoid malignancies, but information on specific malignancy subtypes is limited. From the U.S.
Anderson, Lesley   +9 more
core   +1 more source

A pediatric-type follicular lymphoma with marginal zone and monotypic intracytoplasmic plasmacytic differentiation

open access: yesHuman Pathology: Case Reports, 2018
Pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma are rare indolent lymphomas that are distinctive entities with excellent prognoses.
Jerry T. Wong, M.D., Ph.D.   +2 more
doaj   +1 more source

Solvent exposure and malignant lymphoma : a population-based case-control study in Germany [PDF]

open access: yes, 2007
Aims: To analyze the relationship between exposure to chlorinated and aromatic organic solvents and malignant lymphoma in a multi-centre, population-based case-control study.
Baris   +52 more
core   +2 more sources

Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma [PDF]

open access: yes, 2016
Key Points Combining phosphatidylinositol-3-kinase δ inhibition with rituximab, bendamustine, or both is feasible and active in relapsed iNHL.
Barrientos, Jacqueline C.   +14 more
core   +2 more sources

Spontaneous regression of primary endobronchial extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue

open access: yesRespiratory Medicine Case Reports, 2019
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) of pulmonary origin is a relatively rare disease. In particular, reports of MALT lymphoma occurring and localized in the trachea or bronchus have been limited ...
Chiaki Hosoda   +5 more
doaj   +1 more source

Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma [PDF]

open access: yes, 2012
Background: Hodkin s lymphoma is one of the most frequent lymphoma in western world. Despite an overall good prognosis some patients suffer relapsing tumors which are difficult to cure.
Benz, Alexander   +2 more
core   +2 more sources

Epidemiology of marginal zone lymphoma

open access: yesAnnals of Lymphoma, 2021
In 2016 there were an estimated 7,460 newly diagnosed patients with marginal zone lymphoma (MZL) in the US, which comprised 7% of all mature non-Hodgkin lymphomas (NHL). Based on data from the US SEER-18 program from 2001-2017, the age-standardized incidence rate for MZL was 19.6 per 1,000,000 person-years; 9% of MZL cases were splenic MZL (SMZL), 30 ...
James R, Cerhan, Thomas M, Habermann
openaire   +2 more sources

Lymphoma presenting as subcutaneous periorbital nodules

open access: yesClinical Dermatology Review, 2018
A 67-year-old female presented with a several month history of painless enlarging right periorbital growths. Examination showed multiple nontender subcutaneous nodules superior to the right eyebrow.
Lauren N DeMaria   +2 more
doaj   +1 more source

Signet-ring cell lymphoma: clinicopathologic, immunohistochemical, and fluorescence in situ hybridization studies of 7 cases [PDF]

open access: yes, 2017
Context Signet-ring cell lymphoma (SRCL) is a rare morphologic variant of non–Hodgkin lymphoma. Although it was initially reported as a rare morphologic variant of follicular lymphoma (FL), SRCL has to date been described in most types of non–Hodgkin ...
Choi, Haki   +8 more
core   +1 more source

Combination Immunotherapy as a Promising Strategy to Overcome Immunotherapy Resistance: From Emergence to Next‐Generation Approaches

open access: yesAdvanced Science, EarlyView.
This review examines emerging combination immunotherapy strategies tailored to distinct tumor microenvironments and highlights next‐generation biomarkers that guide response prediction and treatment personalization. It integrates lessons from unsuccessful trials, addresses toxicity challenges, and outlines approaches for early biomarker discovery and ...
Asmita Pandey   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy